Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03418324
Title Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Indications

prostate cancer

Therapies

Abiraterone + Carotuximab

Carotuximab + Enzalutamide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.